Onchocerciasis Treatment Global Market Report 2025
상품코드:1769687
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
온코세르키아증 치료 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 예측 기간 동안의 성장은 풍토병 지역에서의 유병률 증가, 수술 절차에 대한 수요 증가, 의료 인프라의 확대, 만성 질환의 유병률 증가, 의료 투자 증가 등의 요인에 기인합니다. 예측 기간의 주요 동향으로는 단일 용량 요법으로의 전환, 거대 고리형 락톤 제제의 발전, Wolbachia를 표적으로 하는 치료법의 출현, 의약품 개발에 인공 지능(AI)의 통합, 소아용 치료제의 개발 등이 있습니다.
눈 관련 질환을 앓는 사람의 수가 증가함에 따라 온코세르키아증 치료제 시장이 성장할 것으로 예상됩니다. 이러한 질환은 감염, 부상, 녹내장 및 백내장과 같은 만성 질환을 비롯한 다양한 시력 및 안구 건강 문제를 포함합니다. 이러한 증가의 주요 원인은 화면 시청 시간의 증가와 디지털 기기에 대한 장시간 노출입니다. 온코세르키아증 치료는 염증과 안구 손상을 유발하는 기생충 감염을 제거함으로써 시력 상실을 예방하고 관리하는 데 중요한 역할을 합니다. 예를 들어, 2024년 5월 미국 질병통제예방센터(CDC)는 40세 이상 미국인 중 약 2,050만 명이 한쪽 눈 이상에 백내장을 앓고 있으며, 이는 해당 연령층의 17.2%를 차지한다고 보고했습니다. 이 수치는 2028년에는 3천만 명에 달할 것으로 예상됩니다. 결과적으로, 눈 관련 문제의 유병률이 증가하면서 온코세르키아증 치료에 대한 수요가 증가하고 있습니다.
수술 절차에 대한 필요성이 증가하는 것도 온코세르키아증 치료 시장의 성장에 기여하고 있습니다. 수술 절차는 질병에 의해 손상된 조직을 제거하거나 복구하기 위한 의학적 개입을 포함하며, 의약품 치료가 실패하거나 합병증이 장기적인 건강 위험을 초래하는 경우에 종종 필요합니다. 일부 환자의 온코세르키아증 질환이 진행 단계로 진행될 경우, 시력 상실이나 변형과 같은 영구적인 손상을 방지하기 위해 수술적 개입이 필요합니다. 이에 대응해 의료 시스템은 수술 능력을 강화하고 고급 기술을 도입함으로써 시장 확장을 지원하고 있습니다. 예를 들어, 2024년 6월, 국제 미용 성형 외과 학회(ISAPS)는 2023년에 전 세계적으로 약 3,500만 건의 미용 시술이 시행되어 전년도에 비해 3.4% 증가했다고 보고했습니다. 외과적 시술은 5.5% 증가했으며, 그 중 1,580만 건 이상이 성형외과 의사에 의해 시행되었습니다. 이러한 수술에 대한 수요의 증가는 오니코케르시아증 치료 시장을 강화하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 온코세르키아증 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 온코세르키아증 치료 시장 : 성장률 분석
세계의 온코세르키아증 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 온코세르키아증 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 온코세르키아증 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 온코세르키아증 치료 시장 : 약제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
이버멕틴
독시사이클린
알벤다졸
목시덱틴
세계의 온코세르키아증 치료 시장 : 치료 전략별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
집단의약품관리국(MDA)
표적 치료
세계의 온코세르키아증 치료 시장 : 투여 방법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사
국소
세계의 온코세르키아증 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 온코세르키아증 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 클리닉
재택 케어
정부와 비정부 프로그램
세계의 온코세르키아증 치료 시장 : 이버멕틴 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
커뮤니티 기반 집단 약물 투여(MDA) 키트
고정용량 병용요법
소아용 제제
세계의 온코세르키아증 치료 시장 : 독시사이클린 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구 캡슐
서방정
항보르바키아 요법과의 병용
병원에서의 처방약에 의한 치료
세계의 온코세르키아증 치료 시장 : 알벤다졸 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단회 복용 경구
이버멕틴과 병용 요법
정부가 제공 예방 화학요법 포장
유행지역 일반의약품약(OTC) 제제
세계의 온코세르키아증 치료 시장 : 목시덱틴 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
장시간 작용형 제제
성인만의 투여 요법
임상 검사 접근 프로그램
제7장 지역별, 국가별 분석
세계의 온코세르키아증 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 온코세르키아증 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
온코세르키아증 치료 시장 : 경쟁 구도
온코세르키아증 치료 시장 : 기업 프로파일
Merck & Co. Inc.
Teva Pharmaceutical Industries Limited
Hetero Labs Limited
Sun Pharmaceutical Industries Limited
Intas Pharmaceuticals Limited
제31장 기타 주요 기업 및 혁신 기업
Dr. Reddy's Laboratories Inc.
Cipla Limited
Endo Inc.
Lupin Limited
Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos-Fundacao Oswaldo Cruz(Fiocruz)
AMGIS Lifescience Ltd.
Drugs for Neglected Diseases initiative(DNDi)
Rakshit Drugs Pvt. Ltd.
Hangzhou Longshine Bio-Tech Co. Ltd.
OREX Pharma Private Limited
Angle Bio Pharma Pvt. Ltd.
Senores Pharmaceuticals Inc.
Avenacy LLC
Dolphin Pharma
Cerata Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
온코세르키아증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
온코세르키아증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
온코세르키아증 치료 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Onchocerciasis treatment encompasses medical and therapeutic interventions aimed at managing and eliminating infections caused by Onchocerca volvulus, the parasite responsible for river blindness-a disease that primarily impacts the skin and eyes. The key objective of treatment is to eradicate the microfilariae (immature larvae) to reduce transmission, alleviate symptoms, and lower the risk of vision impairment.
The primary drugs used in onchocerciasis treatment include ivermectin, doxycycline, albendazole, and moxidectin. Ivermectin is an antiparasitic agent employed in treating several parasitic diseases, including onchocerciasis (river blindness), by targeting and killing the parasite's larvae (microfilariae). Treatment approaches consist of mass drug administration (MDA) and targeted therapies, utilizing various forms of administration such as oral, injectable, and topical options. These treatments are distributed through hospital pharmacies, retail pharmacies, and online platforms, and they cater to end-users including hospitals and clinics, home-based care settings, and government as well as non-governmental initiatives.
The onchocerciasis treatment market research report is one of a series of new reports from The Business Research Company that provides onchocerciasis treatment market statistics, including the onchocerciasis treatment industry global market size, regional shares, competitors with the onchocerciasis treatment market share, detailed onchocerciasis treatment market segments, market trends, opportunities, and any further data you may need to thrive in the onchocerciasis treatment industry. This onchocerciasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period is due to an increase in patients suffering from eye-associated issues, an increase in parasitic infections, an increase in the number of targeted treatment centers, a rise in education campaigns, and an increase in the geriatric population.
The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period is due to factors such as rising prevalence in endemic regions, rising demand for surgical procedures, expanding healthcare infrastructure, growing prevalence of chronic diseases, and increasing healthcare investments. Major trends in the forecast period include a shift towards single-dose regimens, advancements in macrocyclic lactone formulations, the emergence of Wolbachia-targeting therapies, the integration of artificial intelligence (AI) in drug discovery, and the development of pediatric-specific treatments.
The increasing number of individuals suffering from eye-related conditions is expected to drive the growth of the onchocerciasis treatment market. These conditions encompass a range of vision and ocular health issues, including infections, injuries, and chronic diseases such as glaucoma and cataracts. A key contributor to this rise is the extended screen time and prolonged exposure to digital devices. Onchocerciasis treatment plays a crucial role in preventing and managing vision loss by eliminating the parasitic infection responsible for inflammation and ocular damage. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that approximately 20.5 million Americans over the age of 40 have cataracts in at least one eye, representing 17.2% of that age group. The number is expected to reach nearly 30 million by 2028. Consequently, the growing prevalence of eye-related issues is boosting the demand for onchocerciasis treatment.
The increasing need for surgical procedures is also contributing to the growth of the onchocerciasis treatment market. Surgical procedures involve medical interventions to remove or repair tissues affected by disease and are often required when drug treatments fail or complications pose long-term health risks. The progression of onchocerciasis to advanced stages in some patients necessitates surgical intervention to prevent permanent damage such as vision loss or disfigurement. In response, healthcare systems are enhancing their surgical capabilities and adopting advanced techniques, thereby supporting market expansion. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that nearly 35 million aesthetic procedures were performed globally in 2023, marking a 3.4% increase from the previous year. Surgical procedures rose by 5.5%, with more than 15.8 million performed by plastic surgeons. This growing demand for surgeries is reinforcing the onchocerciasis treatment market.
Leading companies in the onchocerciasis treatment market are prioritizing the development of innovative antiparasitic drugs to enhance treatment outcomes and accessibility. These drugs target parasites such as worms and protozoa, which are responsible for infections like onchocerciasis. In December 2024, Medicines Development for Global Health (MDGH), an Australian non-profit biopharmaceutical company, received approval from the Ghana Food and Drugs Authority for Moxidectin 2 mg oral tablets, intended for the treatment of river blindness in individuals aged four and above. This approval paves the way for community-wide mass drug administration initiatives in Ghana, utilizing moxidectin's superior efficacy and extended duration of action compared to ivermectin. Through this initiative, MDGH aims to increase access to a more effective treatment, supporting widespread implementation in endemic areas.
Major players in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, and Cerata Pharmaceuticals Inc.
North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onchocerciasis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the onchocerciasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The onchocerciasis treatment market consists of revenues earned by entities providing services such as mass drug administration (MDA) campaigns, community-based health outreach, disease surveillance and diagnostics, vector control initiatives, and public health education. The market value includes the value of related goods sold by the service provider or included within the service offering. The onchocerciasis treatment market also includes sales of antiparasitic drugs, diagnostic kits, drug delivery tools, and protective supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Onchocerciasis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on onchocerciasis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for onchocerciasis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The onchocerciasis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Type: Ivermectin; Doxycycline; Albendazole; Moxidectin
2) By Treatment Strategy: Mass Drug Administration (MDA); Targeted Treatment
3) By Mode Of Administration: Oral; Injectables; Topical
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospitals And Clinics; Home Care Settings; Government And Non-Governmental Programs
Subsegments:
1) By Ivermectin: Oral Tablets; Community-Based Mass Drug Administration (MDA) Kits; Fixed-Dose Combination Therapies; Pediatric Formulations
2) By Doxycycline: Oral Capsules; Extended-Release Tablets; Combination With Anti-Wolbachia Therapy; Hospital-Based Prescription Treatments
3) By Albendazole: Single-Dose Oral Tablets; Combination Therapy With Ivermectin; Government-Supplied Preventive Chemotherapy Packages; Over-The-Counter (OTC) Formulations In Endemic Areas
3. Onchocerciasis Treatment Market Trends And Strategies
4. Onchocerciasis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Onchocerciasis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Onchocerciasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Onchocerciasis Treatment Market Growth Rate Analysis
5.4. Global Onchocerciasis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Onchocerciasis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Onchocerciasis Treatment Total Addressable Market (TAM)
6. Onchocerciasis Treatment Market Segmentation
6.1. Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ivermectin
Doxycycline
Albendazole
Moxidectin
6.2. Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass Drug Administration (MDA)
Targeted Treatment
6.3. Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectables
Topical
6.4. Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Home Care Settings
Government And Non-Governmental Programs
6.6. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Community-Based Mass Drug Administration (MDA) Kits
Fixed-Dose Combination Therapies
Pediatric Formulations
6.7. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Capsules
Extended-Release Tablets
Combination With Anti-Wolbachia Therapy
Hospital-Based Prescription Treatments
6.8. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Onchocerciasis Treatment Market
9.1. China Onchocerciasis Treatment Market Overview
9.2. China Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Onchocerciasis Treatment Market
10.1. India Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Onchocerciasis Treatment Market
11.1. Japan Onchocerciasis Treatment Market Overview
11.2. Japan Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Onchocerciasis Treatment Market
12.1. Australia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Onchocerciasis Treatment Market
13.1. Indonesia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Onchocerciasis Treatment Market
14.1. South Korea Onchocerciasis Treatment Market Overview
14.2. South Korea Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Onchocerciasis Treatment Market
15.1. Western Europe Onchocerciasis Treatment Market Overview
15.2. Western Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Onchocerciasis Treatment Market
16.1. UK Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Onchocerciasis Treatment Market
17.1. Germany Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Onchocerciasis Treatment Market
18.1. France Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Onchocerciasis Treatment Market
19.1. Italy Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Onchocerciasis Treatment Market
20.1. Spain Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Onchocerciasis Treatment Market
21.1. Eastern Europe Onchocerciasis Treatment Market Overview
21.2. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Onchocerciasis Treatment Market
22.1. Russia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Onchocerciasis Treatment Market
23.1. North America Onchocerciasis Treatment Market Overview
23.2. North America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Onchocerciasis Treatment Market
24.1. USA Onchocerciasis Treatment Market Overview
24.2. USA Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Onchocerciasis Treatment Market
26.1. South America Onchocerciasis Treatment Market Overview
26.2. South America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Onchocerciasis Treatment Market
27.1. Brazil Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Onchocerciasis Treatment Market
28.1. Middle East Onchocerciasis Treatment Market Overview
28.2. Middle East Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Onchocerciasis Treatment Market
29.1. Africa Onchocerciasis Treatment Market Overview
29.2. Africa Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Onchocerciasis Treatment Market Competitive Landscape And Company Profiles
